Skip to main content
. 2023 Jul 26;13:12137. doi: 10.1038/s41598-023-39369-y

Figure 5.

Figure 5

Activation status of quiescent and activated human induced pluripotent stem cell derived cardiac fibroblasts (hiPSC-cFbs) in response to TGF-β and SD208. (a-f) Activation of quiescent and activated hiPSC-cFbs as determined by RT-PCR for ACTA2, COL1A1 and COL3A1 following 4 days in culture. Data presented as mean ± S.E.M. N = 6. *p < 0.05, **p < 0.01, ****p < 0.0001, one-way ANOVA compared with control. (gi) Proliferation was assessed as a percentage change in fluorescence over 48 h compared to baseline. (g) Proliferation of untreated quiescent and activated hiPSC-cFBs. (h) Proliferation of quiescent hiPSC-cFBs in the presence of TGF-β (+ TGF) and following withdrawal of SB431542 (-SB). (i) Proliferation of activated hiPSC-cFBs in response to TGF-β (+ TGF) and TGF-β receptor inhibitors SD208 (+ SD208) and SB431542 (+ SB). Data presented as mean ± S.E.M. N = 3 plates, 24 wells. *p < 0.05, nested one-way ANOVA compared with control.